New Delhi: Those who participated in the clinical trials of Covishield and Covaxin, and actually got both vaccine doses can now access their certificates digitally. The Union Ministry of Health...
New Delhi: ZyCOV-D vaccine for adolescents above the age of 12 will be available in India next month. The price of this new COVID-19 vaccine, which got emergency use approval...
New Delhi: Johnson & Johnson (J & J) has applied to India’s Central Drugs Standard Control Organisation (CDSCO) for permission to conduct a study of its COVID vaccine Janssen among...
The subject expert committee (SEC) of Drugs Controller General of India (DCGI) has recommended granting emergency use approval (EUA) to Zydus Cadila’s three-dose COVID-19 vaccine for children above the age...
Nearly 39 million people in India did not receive their second dose of COVID-19 vaccine within the stipulated time. This is according to the Union government’s response to a Right...
Bharat Biotech’s top honcho is confident about the efficacy of the intra-nasal vaccine against COVID-19 that the Hyderabad-based company is developing. Bharat Biotech’s Chairman and MD Dr Krisha Ella said...
Pune: Serum Institute of India (SII) founder and chairman Dr Cyrus Poonawalla is not in favour of mixing COVID-19 vaccines. He is of the opinion that mixing could lead to...
New Delhi: Bharat Biotech’s nasal vaccine to fight COVID-19 has been cleared by regulators for Phase 2/3 trial. According to the Ministry of Science and Technology, the Phase 1 trial...
New Delhi: Foreign nationals residing in India will now be eligible to get COVID-19 vaccine in India. The Ministry of Health & Family Welfare announced that foreign nationals will have...
New Delhi: Combining Covaxin and Covishield results in better immunogenicity than two doses of the same vaccine, the Indian Council of Medical Research (ICMR) has said. The findings are based...